325 related articles for article (PubMed ID: 3167869)
1. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
4. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
[TBL] [Abstract][Full Text] [Related]
6. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
Waldman FM; Chew K; Ljung BM; Goodson W; Hom J; Duarte LA; Smith HS; Mayall B
Mod Pathol; 1991 Nov; 4(6):718-22. PubMed ID: 1724086
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
[TBL] [Abstract][Full Text] [Related]
8. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
9. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
[TBL] [Abstract][Full Text] [Related]
10. Measuring potential doubling times of murine tumors using flow cytometry.
Carlton JC; Terry NH; White RA
Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry.
Tsurusawa M; Aoyama M; Saeki K; Fujimoto T
Leukemia; 1995 Nov; 9(11):1921-5. PubMed ID: 7475284
[TBL] [Abstract][Full Text] [Related]
12. S-phase arrest of nutrient deprived lung cancer cells.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
[TBL] [Abstract][Full Text] [Related]
13. A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine.
Sasaki K; Murakami T; Takahashi M
Cytometry; 1987 Sep; 8(5):526-8. PubMed ID: 3311660
[TBL] [Abstract][Full Text] [Related]
14. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
15. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Gunduz N
Cytometry; 1985 Nov; 6(6):597-601. PubMed ID: 3933924
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
Sasaki K; Murakami T; Takahashi M
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2338-44. PubMed ID: 2751315
[TBL] [Abstract][Full Text] [Related]
19. [Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
Kanno M; Takeda Y; Nakamura S
Nihon Rinsho; 1992 Oct; 50(10):2333-7. PubMed ID: 1280304
[TBL] [Abstract][Full Text] [Related]
20. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
